A detailed history of Ensign Peak Advisors, Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 14,015 shares of PRCT stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,015
Previous 14,015 -0.0%
Holding current value
$1.31 Million
Previous $856,000 31.07%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$45.73 - $69.19 $201,212 - $304,436
4,400 Added 45.76%
14,015 $856,000
Q1 2024

May 14, 2024

BUY
$40.38 - $50.75 $388,253 - $487,961
9,615 New
9,615 $475,000
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $114,021 - $186,898
3,690 New
3,690 $153,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.17B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.